KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Community Health Systems (CYH) Cash & Equivalents (2016 - 2025)

Community Health Systems (CYH) has disclosed Cash & Equivalents for 17 consecutive years, with $123.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 272.73% year-over-year to $123.0 million, compared with a TTM value of $123.0 million through Sep 2025, up 272.73%, and an annual FY2024 reading of $37.0 million, changed N/A over the prior year.
  • Cash & Equivalents was $123.0 million for Q3 2025 at Community Health Systems, down from $456.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.3 billion in Q3 2021 and bottomed at $33.0 million in Q3 2024.
  • Average Cash & Equivalents over 5 years is $391.4 million, with a median of $222.0 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents tumbled 76.82% in 2022, then surged 1069.23% in 2025.
  • Year by year, Cash & Equivalents stood at $507.0 million in 2021, then plummeted by 76.73% to $118.0 million in 2022, then fell by 22.88% to $91.0 million in 2023, then plummeted by 59.34% to $37.0 million in 2024, then soared by 232.43% to $123.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for CYH at $123.0 million in Q3 2025, $456.0 million in Q2 2025, and $431.0 million in Q1 2025.